These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9428590)

  • 21. Biodistribution of the Cuban anti-meningococcal vaccine, VA-MENGOC-BC, in Balb/c mice.
    Pérez-Martín O; Lastre-González M; Díaz-Orellana M; Zayas-Vignier C; Caso R; Hernández I; Sierra-González G
    Arch Med Res; 1997; 28(1):37-40. PubMed ID: 9078585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Establishment and assessment of the mouse model for spinal cord injury].
    Lu M; Quan Z; Liu B; Jiang D; Ou Y; Zhao J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Aug; 22(8):933-8. PubMed ID: 18773808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms.
    Opal SM; Palardy JE; Chen WH; Parejo NA; Bhattacharjee AK; Cross AS
    J Infect Dis; 2005 Dec; 192(12):2074-80. PubMed ID: 16288370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a booster dose of serogroup B meningococcal vaccine on antibody response to Neisseria meningitidis in mice vaccinated with different immunization schedules.
    Gioia CA; de Sousa AB; Cruz SC; Junior FC; Andrade AF; Sassi RM; Frasch CE; Milagres LG
    FEMS Immunol Med Microbiol; 2005 Apr; 44(1):35-42. PubMed ID: 15780576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Induction of anti-meningitis immunity using the synthetic peptides. I. The immunoreactive synthetic fragments of porin A from Neisseria meningitidis].
    Koroev DO; Kotel'nikova OV; Vol'pina OM; Zhmak MN; Kupriianova MA; Agafonova SA; Alliluev AP; Litvinov IS; Nesmeianov VA; Ivanov VT
    Bioorg Khim; 2000 May; 26(5):323-9. PubMed ID: 10900502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental study of immunological tolerance induced by cytotoxic T lymphocyte-associated antigen 4 immunoglobulin in fresh bone allografts].
    Guo C; Dai K; Tang T
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 May; 19(5):381-5. PubMed ID: 15960444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.
    Cuello M; Cabrera O; Martinez I; Del Campo JM; Camaraza MA; Sotolongo F; Pérez O; Sierra G
    Vaccine; 2007 Feb; 25(10):1798-805. PubMed ID: 17240485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
    Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E
    Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II meningococcal B vesicle vaccine trial in New Zealand infants.
    Jackson C; Lennon DR; Sotutu VT; Yan J; Stewart JM; Reid S; Crengle S; Oster P; Ypma E; Aaberge I; Mulholland K; Martin DR
    Arch Dis Child; 2009 Oct; 94(10):745-51. PubMed ID: 18838420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Characteristics of Neisseria meningitidis strains isolated from patients with symptoms of meningococcal meningitis in Poland in 1995-2000].
    Grzybowska W; Tyski S
    Med Dosw Mikrobiol; 2001; 53(2):117-32. PubMed ID: 11913341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inoculation of Balb/c mice with live attenuated tachyzoites protects against a lethal challenge of Neospora caninum.
    Bartley PM; Wright S; Chianini F; Buxton D; Innes EA
    Parasitology; 2008 Jan; 135(Pt 1):13-21. PubMed ID: 17767798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Meningococcal disease and VA-MENGOC BC in minors less than 1 year of age. Cuba, 1983 to 1991].
    Rico Cordeiro O; Jiménez Barreras R; Pereira Colls C
    Rev Cubana Med Trop; 1996; 48(1):34-9. PubMed ID: 9768267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of vaccine potential of the Neisseria-specific protein NMB0938.
    Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D
    Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-idiotype induced protection against Neisseria meningitidis serogroup C bacteremia.
    Westerink MA; Giardina PC
    Microb Pathog; 1992 Jan; 12(1):19-26. PubMed ID: 1560751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The virulence in mice of Neisseria meningitidis variants differing in free endotoxin activities and cell envelope properties.
    Andersen BM; Solberg O
    NIPH Ann; 1984 Dec; 7(2):47-59. PubMed ID: 6442402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Release of endotoxin from Neisseria meningitidis. A short survey with a preliminary report on virulence in mice.
    Andersen BM; Solberg O
    NIPH Ann; 1980 Dec; 3(2):49-55. PubMed ID: 6784043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzylpenicillin in mice. Effect of meningococci on plasma concentrations.
    Solberg O; Andersen BM
    NIPH Ann; 1985 Jun; 8(1):3-12. PubMed ID: 3932902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preventive and therapeutic action of sera to the Re mutant of Salmonella minnesota in experimental generalized meningococcal infection].
    Mironova TK; Apollonin AV; Krokhina MA; Kostiukova NN; Likhoded VG
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Apr; (4):58-62. PubMed ID: 3137743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unusual antineisserial activity expressed by a systemic isolate of Neisseria meningitidis. antimeningococcal effect and properties.
    Allunans J; Bøvre K
    Scand J Infect Dis; 2001; 33(7):516-22. PubMed ID: 11515762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.